Aipedia: Pharmacists and pharmacies

AI scribes and pharmacy consultation records

Aipedia, by the Apex broking team · Last reviewed 2026-10-30

You can use an AI scribe to draft consultation notes, but you must check and correct the record and tell patients before recording. An inaccurate note can undermine the defence of a claim that the consultation itself would have survived.

Part of: AI in pharmacists and pharmacies

In short

Pharmacists in consultation rooms, clinical services and GP practices are starting to use ambient scribes and AI note tools that listen to a consultation and draft a record. The GPhC position statement lists transcribing patient notes as an AI use and says pharmacists must check outputs, protect data and explain AI use to patients. In NHS settings in England, NHS England guidance requires a DPIA and clinical safety work, tells users to review and approve outputs, and says patients must be told before processing starts. The record is often the main evidence in a claim, so errors in an AI note can turn a defensible decision into a hard one.

How pharmacists use AI scribes

An ambient scribe records the conversation, transcribes it and, in many products, summarises it into a structured note for the patient record. Pharmacists use them in private consultations, in NHS clinical services, in structured medication reviews in GP practices and in hospital clinics. Simpler AI note tools tidy dictated notes or turn bullet points into prose. The appeal is time back with the patient. The risk is a note that reads well but records something that was not said, or leaves out something that was.

The duties that apply

The relevant duties are:

Checking outputs: the GPhC position statement names transcribing patient notes as an AI use and requires pharmacists to check outputs for accuracy and misleading content.
Standard 7, confidentiality: recordings and transcripts are patient data; the tool must be approved through the owner's or employer's information governance.
Standard 3 and telling patients: the GPhC says pharmacists should explain AI use to patients and seek consent where necessary.
NHS settings: the NHS England guidance on ambient scribing requires a DPIA, supplier compliance with DCB0129 and deploying-organisation work under DCB0160, including a safety case and hazard log. Users must review and approve outputs, and patients must be told before processing starts and given a chance to object.

The NHS England guidance also notes that tools which only transcribe are likely not medical devices, while generative summarisation is likely to be one and must be registered with the MHRA.

What can go wrong

Illustrative scenario: during a medication review a patient says they stopped one medicine weeks ago because of side effects. The scribe's summary records the medicine as "continued, well tolerated". The pharmacist approves the note without reading it closely. A later prescriber relies on the record, the medicine is restarted and the patient is harmed. In the complaint that follows, the record contradicts the patient's account, and the pharmacist cannot show which is right.

Other common errors include mishearing drug names and doses, attributing what a carer said to the patient, and omitting advice the pharmacist gave. Recordings and transcripts may also be kept longer than intended, so retention needs to be set.

What an inaccurate record does to a claim

In a negligence claim the contemporaneous record is often the best evidence of what was asked, advised and decided. A clear, accurate note can defend a reasonable decision even when the outcome was bad. A note that contains AI errors damages the pharmacist's credibility on everything else in it. PI policies usually respond to claims arising from professional services, subject to the terms, and an AI-drafted note is part of that service, but defence counsel can only work with the record that exists. The NHS England guidance says liability for scribes is "complex and largely uncharted" and may default to the deploying organisation, which does not remove the individual pharmacist's regulatory exposure.

Practical controls

You can reduce the risk with these steps:

Use only scribes approved by your owner, practice or trust.
Tell the patient before recording and note any objection.
Read every note in full before approving it, paying attention to drug names, doses and stopped medicines.
Correct errors, do not just add to them.
Know the retention rules for audio and transcripts.
Report systematic errors to the owner and supplier.

Doctors face the same issues; see AI scribes for doctors. See also AI in Pharmacy First, AI in GP-practice medication reviews, what to document about AI use and the pharmacy AI hub.

How Apex helps

Apex arranges indemnity for pharmacists and pharmacy owners. A broker checks how your policy responds where an AI-drafted record is part of the evidence, and whether data issues from recordings sit under PI or cyber cover.

Sources

Frequently asked

Do I need patient consent to use an AI scribe?

The GPhC says to explain AI use and seek consent where necessary. In NHS settings in England, NHS England guidance says patients must be told before processing starts and given the chance to object. Whether consent is the lawful basis should be confirmed with your information governance lead.

Who is responsible for errors in an AI-drafted note?

The pharmacist who approves the note. NHS England guidance stresses the ongoing responsibility of practitioners to review and revise outputs, and the GPhC position statement requires pharmacists to check AI outputs for accuracy.

Is an AI scribe a medical device?

It depends on what it does. NHS England guidance says transcription-only tools are likely not medical devices, but tools that use generative AI to summarise are likely to be and must be registered with the MHRA.

Check your PI covers how you use AI

Tell us about your firm and the work you do. A broker will review how your current PI treats AI-assisted work, or arrange new cover. No fee for a quote. Or call 0117 325 0027.

Start a PI quote Request a callback

Apex Insurance Brokers Limited is authorised and regulated by the Financial Conduct Authority. Registered in England and Wales, company number 07014570. This page is general information about how AI is used in the profession and how insurance may respond. It is not legal, regulatory or insurance advice on your circumstances, and it does not guarantee that cover will be available or on what terms.